China-Biotics (PINK:CHBT)

Valuation Scenarios

Added to GeoBargain List June 14, 2009. ($10.00). 

Data Inputs:

Fiscal Year Ends in March
2009 Tax-Adjusted EPS:  $0.83
2010 Analyst Estimate: $1.30

Date	8/17/09
Price	$12.17
12 Months Trailing EPS a,b	$0.87
Tax-Adjusted 2010 Analyst EPS Estimatesa,b	$1.13
Future EPS Growth Rate Based on Tax-Adjusted 2010 Analyst EPS Estimates a,b	36.1%
Trailing P/E Ratio a,b	13.99
PEG Ratio (P/E divided by growth rate) a,b	0.39

^a CHBT is not paying a full U.S. tax rate.  Therefore, all EPS numbers have been adjusted by the GeoTeam® to reflect a tax rate of 36%.

^b EPS figures are non-GAAP.  Non-GAAP EPS Figures exclude certain non-operating gains and losses as well as certain non-cash items. Non-GAAP information should not be viewed in isolation or as a substitute for reported, or GAAP information . For a more complete explanation of the company's definition of non-GAAP please refer to its financial press releases. The GeoTeam® non-GAAP figures may, from time to time,  differ from company supplied figures.

Short-Term Valuation Scenarios

Date	8/17/09
Price Based on P/E of 25 on Four Quarters Trailing EPS c,d	$21.75
Price Based on P/E of 20 on Four Quarters Trailing EPS c,d	$17.40
Price Based on P/E of 15 on Tax-Adjusted 2010 Analyst EPS Estimates	$16.95

Long-Term (12 Months Forward) Valuation Scenarios

Date	8/17/09
Price Based on P/E of 25 on Tax-Adjusted 2010 Analyst EPS Estimates	$28.25
Price Based on P/E of 20 on Tax-Adjusted 2010 Analyst EPS Estimates	$22.60

Peg Ratio Analysis - Common rule of thumb that PEG ratio should be less than 1.0

PEG Ratio Less than 1?

YES

These scenarios are not investment advice, but are scenarios based on some commonly used investment guidelines.  They are provided to aid investors in making their own investment decisions.